Finished
Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy
NCT05022576 · Post Graduate Institute of Medical Education and Research, Chandigarh · Updated 26 Aug 2021
- What is being tested
- Robotic arm assisted PSMA PET/CT guided prostate biopsy
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 78 people. The full rules are on the registry page.
- Where
- India
- When
- Starts or started 30 Jan 2019, ends 30 Sept 2020. Registered 26 Aug 2021.
- Results
- None posted yet.
In the researchers' words
Gallium-68 prostate-specific-membrane-antigen (Ga-68 PSMA) PET/CT is being used in Prostate cancer imaging. In the present study, we aimed to evaluate the efficacy and safety of robotic arm-assisted Ga-68 PSMA PET/CT-guided transgluteal prostatic biopsy. Seventy-eight participants with a clinical suspicion of PCa were recruited from January 2019 to September 2020. All the patients underwent whole-body Ga-68 PSMA PET/CT. The patients with PSMA-avid lesion in the prostate underwent robotic arm-assisted PET-guided transgluteal biopsies. The degree of pain during the procedure, procedure-related complications and histopathology were evaluated.
Sites
- Department of Nuclear Medicine, PGIMERChandigarh, Chandigarh, India